CHLOE KUDIRKA: Open Payments
NPI 1104602119 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $1,033
Food & beverage: $961Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $378 |
| Galderma Laboratories, L.P. | 2 | $163 |
| UCB, Inc. | 2 | $158 |
| Amgen Inc. | 5 | $115 |
| ABBVIE INC. | 4 | $99 |
| STRATA Skin Sciences, Inc. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| PFIZER INC. | 1 | $23 |
| LEO Pharma Inc. | 1 | $19 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $15 |
Products named: TREMFYA, NEMLUVIO, Bimzelx, Otezla, SKYRIZI, XTRAC, COSENTYX, CIBINQO.
Industry payments across CA — which companies pay providers there.
